MZ SKIN Revenue and Competitors

London, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • MZ SKIN's estimated annual revenue is currently $5.5M per year.(i)
  • MZ SKIN's estimated revenue per employee is $140,000

Employee Data

  • MZ SKIN has 39 Employees.(i)
  • MZ SKIN grew their employee count by 26% last year.

MZ SKIN's People

NameTitleEmail/Phone
1
Chief Digital Officer (CDO)Reveal Email/Phone
2
Head Data AnalysisReveal Email/Phone
3
Head Commercial, GlobalReveal Email/Phone
4
Head MarketingReveal Email/Phone
5
Finance DirectorReveal Email/Phone
6
Assistant NPD ManagerReveal Email/Phone
7
Senior Marketing ManagerReveal Email/Phone
8
Strategy ManagerReveal Email/Phone
9
Ecommerce ManagerReveal Email/Phone
10
Digital Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.5M3926%N/AN/A
#2
$0.3M2100%N/AN/A
#3
$4.9M3525%$35.5MN/A
#4
$22.1M15840%N/AN/A
#5
$14.8M10628%N/AN/A
#6
$21.4M15319%N/AN/A
#7
$37M26440%N/AN/A
#8
$9.1M6538%N/AN/A
Add Company

What Is MZ SKIN?

Known as “The Eye Doctor”, Dr Maryam Zamani has a global reputation for her meticulous attention to detail and sought-after surgical and non-surgical techniques in advanced cosmetic facial treatments, guaranteed to deliver the most natural of results. \n\nWith over 20 years of clinical experience, Dr Zamani created her own high-performance skincare range based on her three-step philosophy of Reveal, Enhance and Protect. \n\nThis award-winning and science-backed collection maximises visible results. Each product is expertly formulated with pioneering ingredients and is clinically trialled for beautiful skin, the ultimate at-home hybrid between Dr Zamani’s clinic and skin enhancing treatments.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$5.5M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.3M390%$20.1M
#2
$4.4M39-5%N/A
#3
$6.2M390%$469.4M
#4
$3.2M395%N/A
#5
$6.4M39-5%N/A